Skip to main content
Top
Published in: European Journal of Trauma and Emergency Surgery 3/2023

Open Access 21-01-2023 | Original Article

The potential impact of coagulation factor XIII in trauma-induced coagulopathy – a retrospective case series analysis

Authors: Michaela Wilhelmi, Alexander Albrecht, Christian Macke, Mathias Wilhelmi, Mohammed Omar, Marcel Winkelmann, Jan-Dierk Clausen

Published in: European Journal of Trauma and Emergency Surgery | Issue 3/2023

Login to get access

Abstract

Background

The role of factor XIII (FXIII) in trauma-induced coagulopathy (TIC) is not fully understood.

Methods

We evaluated FXIII supplementation in severely injured patients with persistent bleeding. This was a retrospective case series analysis.

Results

Twenty-four patients received FXIII concentrate within 24 h of admission for bleeding that continued after transfusion of > 6 U red blood cells (RBCs); control patients (n = 27) did not receive FXIII concentrate. Both study groups were similar regarding injury severity score and global coagulation tests, but FXIII activity levels were significantly higher and lactate levels significantly lower in the control group, respectively. The differences in FXIII activity between the groups could be attributed to a more severe trauma-induced coagulopathy in FXIII-deficient patients, as demonstrated by lower fibrinogen and higher lactate levels. The median dose of FXIII concentrate within 24 h of admission was 2500 IU (IQR: 1250–4375). Median 24-h transfusion of RBCs (primary study endpoint) was significantly higher in the FXIII group versus controls (10.0 U, IQR 5–14 U vs. 2, IQR 0–6 U; p < 0.01). Subsequently, while patients were in the intensive care unit, there was no statistically significant difference regarding RBC transfusion anymore and the overall clinical outcomes were similar in both patient groups.

Conclusions

The substitution of FXIII in patients who were more seriously compromised due to higher lactate levels and who presented with initially more severe bleedings than patients in the control group, resulted in a comparable transfusion necessity after 24 h. Thus, we guess that the substitution of FXIII in severely injured patients with ongoing bleeding might have an impact on their clinical outcome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):98.CrossRefPubMedPubMedCentral Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):98.CrossRefPubMedPubMedCentral
2.
go back to reference Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, Hell T, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017;4(6):e258–71.CrossRefPubMed Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, Hell T, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017;4(6):e258–71.CrossRefPubMed
3.
go back to reference Stein P, Kaserer A, Sprengel K, Wanner GA, Seifert B, Theusinger OM, et al. Change of transfusion and treatment paradigm in major trauma patients. Anaesthesia. 2017;72(11):1317–26.CrossRefPubMed Stein P, Kaserer A, Sprengel K, Wanner GA, Seifert B, Theusinger OM, et al. Change of transfusion and treatment paradigm in major trauma patients. Anaesthesia. 2017;72(11):1317–26.CrossRefPubMed
4.
go back to reference Schlimp CJ, Cadamuro J, Solomon C, Redl H, Schöchl H. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfus. 2013;11(4):510–7.PubMedPubMedCentral Schlimp CJ, Cadamuro J, Solomon C, Redl H, Schöchl H. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfus. 2013;11(4):510–7.PubMedPubMedCentral
5.
go back to reference Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR. In vitro factor XIII supplementation increases clot firmness in rotation thromboelastometry (ROTEM). Thromb Haemost. 2010;104(2):385–91.PubMed Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR. In vitro factor XIII supplementation increases clot firmness in rotation thromboelastometry (ROTEM). Thromb Haemost. 2010;104(2):385–91.PubMed
6.
go back to reference Dickneite G, Herwald H, Korte W, Allanore Y, Denton CP, Matucci CM. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions. Thromb Haemost. 2015;113(4):686–97.CrossRefPubMed Dickneite G, Herwald H, Korte W, Allanore Y, Denton CP, Matucci CM. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions. Thromb Haemost. 2015;113(4):686–97.CrossRefPubMed
7.
go back to reference Levy JH, Goodnough LT. How I use fibrinogen replacement therapy in acquired bleeding. Blood. 2015;125(9):1387–93.CrossRefPubMed Levy JH, Goodnough LT. How I use fibrinogen replacement therapy in acquired bleeding. Blood. 2015;125(9):1387–93.CrossRefPubMed
8.
go back to reference von Rappard S, Hinnen C, Lussmann R, Rechsteiner M, Korte W. Factor XIII deficiency and thrombocytopenia are frequent modulators of postoperative clot firmness in a surgical intensive care unit. Transfus Med Hemother. 2017;44(2):85–92.CrossRef von Rappard S, Hinnen C, Lussmann R, Rechsteiner M, Korte W. Factor XIII deficiency and thrombocytopenia are frequent modulators of postoperative clot firmness in a surgical intensive care unit. Transfus Med Hemother. 2017;44(2):85–92.CrossRef
9.
go back to reference Richardson VR, Cordell P, Standeven KF, Carter AM. Substrates of Factor XIII-A: roles in thrombosis and wound healing. Clin Sci (Lond). 2013;124(3):123–37.CrossRefPubMed Richardson VR, Cordell P, Standeven KF, Carter AM. Substrates of Factor XIII-A: roles in thrombosis and wound healing. Clin Sci (Lond). 2013;124(3):123–37.CrossRefPubMed
10.
go back to reference Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RA, et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost. 2007;97(6):914–21.CrossRefPubMed Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RA, et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost. 2007;97(6):914–21.CrossRefPubMed
11.
go back to reference Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European network of rare bleeding disorders. J Thromb Haemost. 2012;10(4):615–21.CrossRefPubMed Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European network of rare bleeding disorders. J Thromb Haemost. 2012;10(4):615–21.CrossRefPubMed
12.
go back to reference Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh. 1960;5:179–86.PubMed Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh. 1960;5:179–86.PubMed
13.
go back to reference Shainoff JR, Estafanous FG, Yared JP, DiBello PM, Kottke-Marchant K, Loop FD. Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108(3):437–45.CrossRefPubMed Shainoff JR, Estafanous FG, Yared JP, DiBello PM, Kottke-Marchant K, Loop FD. Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108(3):437–45.CrossRefPubMed
14.
go back to reference Gödje O, Gallmeier U, Schelian M, Grünewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg. 2006;54(1):26–33.CrossRefPubMed Gödje O, Gallmeier U, Schelian M, Grünewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg. 2006;54(1):26–33.CrossRefPubMed
15.
go back to reference Gerlach R, Tölle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke. 2002;33(6):1618–23.CrossRefPubMed Gerlach R, Tölle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke. 2002;33(6):1618–23.CrossRefPubMed
16.
go back to reference Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol. 2000;54(3):260–4.CrossRefPubMed Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol. 2000;54(3):260–4.CrossRefPubMed
17.
go back to reference Katzensteiner M, Ponschab M, Schöchl H, Oberladstätter D, Zipperle J, Osuchowski M, Schlimp CJ. Factor XIII measurement and substitution in trauma patients after admission to an intensive care unit. J Clin Med. 2022;11(14):4174.CrossRefPubMedPubMedCentral Katzensteiner M, Ponschab M, Schöchl H, Oberladstätter D, Zipperle J, Osuchowski M, Schlimp CJ. Factor XIII measurement and substitution in trauma patients after admission to an intensive care unit. J Clin Med. 2022;11(14):4174.CrossRefPubMedPubMedCentral
18.
go back to reference Listyo S, Forrest E, Graf L, Korte W. The need for red cell support during non-cardiac surgery is associated to pre-transfusion levels of FXIII and the platelet count. J Clin Med. 2020;9(8):2456.CrossRefPubMedPubMedCentral Listyo S, Forrest E, Graf L, Korte W. The need for red cell support during non-cardiac surgery is associated to pre-transfusion levels of FXIII and the platelet count. J Clin Med. 2020;9(8):2456.CrossRefPubMedPubMedCentral
19.
go back to reference Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the European society of anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34(6):332–95.CrossRefPubMed Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the European society of anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34(6):332–95.CrossRefPubMed
20.
go back to reference Kleber C, Sablotzki A, Casu S, Olivieri M, Thoms K-M, Horter J, Schmitt FCF, Birschmann I, Fries D, Maegele M, et al. The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing. Crit Care. 2022;26:69.CrossRefPubMedPubMedCentral Kleber C, Sablotzki A, Casu S, Olivieri M, Thoms K-M, Horter J, Schmitt FCF, Birschmann I, Fries D, Maegele M, et al. The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing. Crit Care. 2022;26:69.CrossRefPubMedPubMedCentral
21.
go back to reference Duque P, Chasco-Ganuza M, Ortuzar A, Almaraz C, Terradillos E, Pérez-Rus G, Pascual C. Acquired FXIII deficiency is associated with high morbidity. Thromb Haemost. 2022;122:48–56.CrossRefPubMed Duque P, Chasco-Ganuza M, Ortuzar A, Almaraz C, Terradillos E, Pérez-Rus G, Pascual C. Acquired FXIII deficiency is associated with high morbidity. Thromb Haemost. 2022;122:48–56.CrossRefPubMed
Metadata
Title
The potential impact of coagulation factor XIII in trauma-induced coagulopathy – a retrospective case series analysis
Authors
Michaela Wilhelmi
Alexander Albrecht
Christian Macke
Mathias Wilhelmi
Mohammed Omar
Marcel Winkelmann
Jan-Dierk Clausen
Publication date
21-01-2023
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Trauma and Emergency Surgery / Issue 3/2023
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-023-02221-z

Other articles of this Issue 3/2023

European Journal of Trauma and Emergency Surgery 3/2023 Go to the issue